HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Hao Zhang Yue Tang Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Zhang, H. Articles by Hu, S.-s. Search for Related Content PubMed Articles by Zhang, H. Articles by Hu, S.-s. Related Collections Transplantation - heart

J Thorac Cardiovasc Surg 2007;134:1234-1240
© 2007 The American Association for Thoracic Surgery

Cardiopulmonary Support and Physiology

Injection of bone marrow mesenchymal stem cells in the borderline area of infarcted myocardium: Heart status and cell distribution

^a Research Center for Cardiac Regenerative Medicine, the Ministry of Health and Department of Surgery, Fu Wai Hospital, Beijing, China
^b Animal Research Center, Fu Wai Hospital, Beijing, China
^c Unit of Magnetic Resonance Imaging, Fu Wai Hospital, Beijing, China.

Received for publication April 19, 2007; revisions received June 25, 2007; accepted for publication July 19, 2007.

^_* Address for reprints: Sheng-Shou Hu, MD, Chief, Department of Surgery, Director, Research Center for Cardiac Regenerative Medicine, President, Cardiovascular Institute & Fu Wai Hospital, Professor, Chinese Academy of Medical Sciences, 167A Beilishilu, Beijing 100037, Peoples Republic of China. (Email: shengshouhu{at}yahoo.com).

Objective: This study aimed to test the distribution of intramyocardially injected cells in variations in heart status in a porcine model of myocardial infarction.

Methods: Bone marrow–derived mesenchymal stem cells were obtained from male swine and labeled with iron oxide during culture. One week after creation of a myocardial infarction in female swine, the survivors were randomly divided into 4 groups. Cardiopulmonary bypass was set up to arrest the heart, and then labeled cells (1 x 10⁸) were intramyocardially injected into the border zone of the infarcted zone in group 1 (n = 6). The same volume of cells was grafted into the beating heart in group 2 (n = 6). In groups 3 and 4, saline was injected in either the arresting or beating heart. Three days later, cell distribution was assessed by T2* change with magnetic resonance imaging and sex-determining region on Y-chromosome (SRY) with quantitative polymerase chain reaction.

Results: The cells were identified in the heart, spleen, lung, and liver. Most injected cells were localized in the myocardium in groups 1 and 2; however, the amount of cells was much higher in group 1 (T2* change: 22.3 ± 2.2 vs 17 ± 0.84; SRY gene: 0.15 ± 0.062 vs 0.072 ± 0.003).

Conclusions: Even after intramyocardial injection, many cells migrated to extracardiac organs, especially to the spleen. Our results indicated that injection in the arresting heart could favor retaining more cells in the myocardium. Thus, it was an optimal approach to deliver mesenchymal stem cells during open chest surgery.